David Jeffs bought $105k of STME
Chief Executive Officer at Cell MedX Corp.. 15,000,000 shares at an average of $0.01, traded Dec 29, 2023, filed Jan 10, 2024.
Score components
- +25RoleCEO
- +10Trade size$105k at market
- +6Relative to holdingsHoldings up 20%
- +8Price context57% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -32.6%, 3m -32.6%, 6m -43.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001626533-24-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 29, 2023 | AGrant or award Common Shares | +73,959,726 | $0.01 | $518k | 73,959,726 | Jan 10, 2024 |
| Dec 29, 2023 | POpen-market purchase Common Sharesindirect: Daughter | +7,500,000 | $0.01 | $53k | 81,459,726 | Jan 10, 2024 |
| Dec 29, 2023 | POpen-market purchase Common Sharesindirect: Son | +7,500,000 | $0.01 | $53k | 88,959,726 | Jan 10, 2024 |
Related signals
Other insiders at Cell MedX Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | STMEsell Cell MedX Corp. | Amir Vahabzadeh director, owner | $5,667 16,667 shares | -0% | |
| 7Weak | STMEbuy Cell MedX Corp. | Richard Jeffs owner | $3,310 19,399 shares | +1% | |
| 43Moderate | Cell MedX Corp. | Richard Jeffs owner | $101k 14,372,285 shares | +128% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.